Stock 300633 SONOSCAPE MEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials SonoScape Medical Corp.

Equities

300633

CNE100002P91

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
40.4 CNY -1.66% Intraday chart for SonoScape Medical Corp. -2.18% -14.59%
Apr. 29 Nomura Adjusts Sonoscape Medical’s Price Target to 49.97 Yuan From 55.47 Yuan, Keeps at Buy MT
Apr. 26 SonoScape Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,393 1,600 2,020 3,401 2,870 2,413 - -
Enterprise Value (EV) 2 1,393 1,600 2,020 3,235 2,630 2,118 2,060 1,986
P/E ratio 95.6 x -216 x 51.5 x 63.8 x 45 x 31.4 x 24 x 19.5 x
Yield - - - 0.33% 0.68% 0.81% 1.01% 1.44%
Capitalization / Revenue 7.88 x 8.94 x 9.17 x 13.3 x 9.79 x 6.9 x 5.46 x 4.5 x
EV / Revenue 7.88 x 8.94 x 9.17 x 12.6 x 8.97 x 6.06 x 4.66 x 3.7 x
EV / EBITDA 72.8 x -955 x 52.7 x 52.7 x 36.1 x 24.1 x 17.7 x 14.3 x
EV / FCF - - - 78.5 x 60.9 x 32 x 26.3 x 23.7 x
FCF Yield - - - 1.27% 1.64% 3.12% 3.8% 4.23%
Price to Book 6.91 x 7.76 x 5.45 x 8.56 x 6.47 x 4.75 x 4.03 x 3.41 x
Nbr of stocks (in thousands) 405,760 403,836 401,920 427,862 430,653 431,473 - -
Reference price 3 23.90 25.86 31.93 54.83 47.30 40.40 40.40 40.40
Announcement Date 2/28/20 4/23/21 4/14/22 4/11/23 4/11/24 - - -
1CNY in Million2USD in Million3CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 176.8 179 220.2 256.2 293.1 349.6 441.9 536.2
EBITDA 1 19.15 -1.676 38.33 61.36 72.93 87.81 116.6 139.2
EBIT 1 15.03 -6.8 32.88 55.58 65.63 77.7 105.9 129.3
Operating Margin 8.5% -3.8% 14.93% 21.7% 22.39% 22.22% 23.97% 24.11%
Earnings before Tax (EBT) 1 15.19 -6.856 38.75 55.51 65.5 79.33 107.1 130.9
Net income 1 14.32 -7.121 37.69 53.75 62.82 76.15 100.4 123.3
Net margin 8.1% -3.98% 17.12% 20.98% 21.43% 21.78% 22.72% 22.99%
EPS 2 0.2500 -0.1200 0.6200 0.8600 1.050 1.286 1.686 2.070
Free Cash Flow 1 - - - 41.2 43.22 66.1 78.21 83.93
FCF margin - - - 16.08% 14.75% 18.91% 17.7% 15.65%
FCF Conversion (EBITDA) - - - 67.14% 59.26% 75.28% 67.07% 60.31%
FCF Conversion (Net income) - - - 76.65% 68.8% 86.81% 77.9% 68.08%
Dividend per Share 2 - - - 0.1800 0.3200 0.3290 0.4078 0.5804
Announcement Date 2/28/20 4/23/21 4/14/22 4/11/23 4/11/24 - - -
1USD in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 - 74.32 68.26 78.35 58.07 90.18 - 66.16 82.12 92.83 115.9 - -
EBITDA - - - - - - - - - - - - -
EBIT 1 - 16.95 21.56 19.52 8.011 17.29 25.38 15.33 20.04 19.22 25.11 - -
Operating Margin - 22.81% 31.59% 24.91% 13.8% 19.17% - 23.16% 24.41% 20.71% 21.67% - -
Earnings before Tax (EBT) 1 - - - 19.47 7.935 17.26 25.28 15.4 21.01 20.19 21.19 - -
Net income 1 25.58 - - 18.49 6.506 18.5 25.06 13.83 19.96 19.18 20.92 - -
Net margin - - - 23.6% 11.2% 20.51% - 20.9% 24.3% 20.66% 18.06% - -
EPS 2 0.4086 0.2900 0.3220 0.3129 0.1080 0.3067 - 0.2318 0.3303 0.3174 0.3463 - -
Dividend per Share 2 - - - - - 0.3200 - - - - 0.3669 - -
Announcement Date 8/23/22 4/11/23 4/26/23 8/22/23 10/25/23 4/11/24 4/11/24 4/26/24 - - - - -
1USD in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - - - 166 240 295 352 426
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - 41.2 43.2 66.1 78.2 83.9
ROE (net income / shareholders' equity) 7.47% -3.36% 16.8% 14.6% 15.2% 15.4% 17.3% 18.1%
ROA (Net income/ Total Assets) - - - 11.2% - 13.4% 14.2% 14.8%
Assets 1 - - - 479.1 - 568.4 708.2 832.5
Book Value Per Share 2 3.460 3.330 5.860 6.400 7.310 8.510 10.00 11.80
Cash Flow per Share 2 0.4700 0.6700 0.7500 1.110 1.140 1.280 1.550 1.820
Capex 1 22.4 23.9 23.2 27.6 24.4 12.4 17.9 17
Capex / Sales 12.66% 13.35% 10.53% 10.77% 8.33% 3.56% 4.05% 3.17%
Announcement Date 2/28/20 4/23/21 4/14/22 4/11/23 4/11/24 - - -
1USD in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for SonoScape Medical Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
40.4 CNY
Average target price
49.46 CNY
Spread / Average Target
+22.42%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Imaging Systems

1st Jan change Capi.
SONOSCAPE MEDICAL CORP. Stock SonoScape Medical Corp.
-14.59% 2.41B
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Stock Shanghai United Imaging Healthcare Co., Ltd.
-4.01% 14.91B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Wandong Medical Technology Co.,Ltd.
-11.01% 1.48B
CORETAG, INC. Stock Coretag, Inc.
-.--% 1.12B
NANO-X IMAGING LTD. Stock Nano-X Imaging Ltd.
+58.24% 583M
GUERBET Stock Guerbet
+94.87% 515M
DETECTION TECHNOLOGY OYJ Stock Detection Technology Oyj
+12.77% 244M
DRTECH CORPORATION Stock DRTECH Corporation
+0.12% 230M
VIEWORKS CO., LTD. Stock Vieworks Co., Ltd.
+4.07% 188M
INTROMEDIC CO., LTD. Stock IntroMedic Co., Ltd.
-.--% 179M
Medical Imaging Systems
  1. Stock Market
  2. Equities
  3. 300633 Stock
  4. Financials SonoScape Medical Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW